Information Provided By: 
Fly News Breaks for October 17, 2018
UNH
Oct 17, 2018 | 06:34 EDT
RBC Capital analyst Frank Morgan raised his price target on UnitedHealth to $308 and kept his Outperform rating after its Q3 earnings beat, saying the results were strong across its business lines. The analyst notes that the company saw a rebound in its Medical care ratio, and the stock was further supported by the management's sentiment of strong momentum persisting into 2019. Morgan further states that the 2019 selling season for UnitedHealth's OptumRX was solid and its medical cost trends are consistent with expectations.
News For UNH From the Last 2 Days
UNH
Apr 25, 2024 | 10:38 EDT
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Biohaven Pharmaceutical... To see the rest of the story go to thefly.com. See Story Here
UNH
Apr 24, 2024 | 16:14 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
UNH
Apr 24, 2024 | 14:22 EDT
UNH
Apr 24, 2024 | 13:51 EDT
